2021 Oral Pathology Symposium: Potential Oral Malignant Disorders and their Mimickers

 

A Practical Approach to Diagnosing Early Malignancies Involving the Soft
and Hard Tissues of the Oral 
& Maxillofacial Region
Presented by Ngozi Nwizu, BDS, MMSc, PhD


Course Synopsis

Established cancers are fairly easy to detect because of their obvious clinical presentation. They often present as a mass with evidence of pain, ulceration, bleeding, fixation to underlying structures and limitation of movement. The challenge is to detect those not so obvious features that indicate early malignant change.

 

Do you know the varied presentations of early oral cancer? Would you recognize an early cancer when it presents in the mouth, the skin of the face, scalp, behind the ear or neck of the patient? Are you able to recognize the signs of early malignancy involving the gingiva or jaw bones? Do you know how to examine the oropharyngeal region for signs of early cancer? Do you know the appropriate steps to take to investigate a suspicious lesion suggestive of early malignant transformation? Do you know the necessary steps to take to investigate a suspicious lesion and arrive at a definitive diagnosis? Are you familiar with how to manage such patients?

 

Oral cancer 5-year survival rates hover around 66% mainly because oral malignancies are not detected early enough. This course will cover the detection, investigation, diagnosis and management of a wide range of early malignancies involving the soft and hard tissues of the oral and maxillofacial region, including the overlying skin.

 

Objectives

Upon completion of this session, you will be able to:

  • Develop a better understanding into the diverse clinical presentations of early malignancies involving the soft and hard tissues of the oral and maxillofacial region
  • Learn how to develop a systematic approach to identifying and investigating diverse presentations of early malignancies of the oral and maxillofacial region
  • Be conversant with how to manage each of these different malignancies.


 

Red and Ulcerative Oral Mucosal Diseases Mimicking Oral Cancer; Diagnosis and Management Strategies
Presented by Nadarajah Vigneswaran, BDS, DrMedDent, DMD


Course Synopsis

A number of benign red, white and ulcerative oral mucosal lesions may mimic oral precancer and cancer. Since there is no single, gold standard screening test to distinguish benign inflammatory/reactive oral mucosal (Class II) lesions from oral premalignant and malignant (Class I) lesions. Many benign oral mucosal lesions can be misdiagnosed as malignant and are biopsied. In this presentation, I will review the clinical features, differential diagnoses and treatment options of most common red, white and ulcerative oral mucosal diseases of reactive, infectious and autoimmune etiologies.

Objectives

Upon completion of this session, you will be able to:

  • Learn the critical clinical history and features that are useful in distinguishing premalignant and malignant oral mucosal lesions from their benign mimics
  • Discuss the clinical and optical features that distinguish these lesions from oral cancer and its precursors
  • Review both local and systemic treatment guidelines used for treating common oral ulcerative lesions.

 

Update on Principles of Intraoral Biopsy, including the Do's & Don'ts of the Paperwork
Presented by Kalu Ogbureke, BDS, DMSc, JD, MSc


Course Synopsis

This course will provide an update and refresher for the dentist and other clinicians involved in the biopsy of orofacial lesions, on the basic procedures for obtaining optimal biopsy specimens and providing/completing pertinent information on the Biopsy Request Form. Oral and maxillofacial/head and neck pathologists quite often receive biopsy specimens deemed “inadequate” for histopathologic diagnosis. In additional to issues of the size and nature of submitted materials, shortfalls are related to inadequately completed Biopsy Request Form. Since pathologists are tasked with the responsibility of assembling all the pieces of a jigsaw puzzle (history, clinical findings, radiographic, and histopathologic findings) in order to arrive at a definitive diagnosis, it is often necessary that the clinician requesting a pathology report/diagnosis provide pertinent information necessary to complement the histopathologic findings.

Objectives

Upon completion of this session, you will be able to:

  • Review basic procedures for obtaining optimal biopsy specimens
  • Become familiar with various issues relating to inadequate or improper tissue sampling and specimen collection, and understanding of how these may interfere with histopathologic interpretation
  • Discuss potential diagnostic pitfalls (some with legal ramifications) that may occur as a result of suboptimal biopsy request.

 


Sign Up Today!

 

As a courtesy, please register in advance to receive presentation links, course handouts and other timely information. For your convenience, registration will 24 hours prior to course date.

Live Interactive Webinars are considered as in-classroom setting CE hours by the Texas State Board of Dental Examiners.

Continuing education credits awarded for participation in this Live Interactive Webinar may not apply as in person/ / in-classroom CE hours towards license renewal in all states. It is the responsibility of each participant to verify the requirements of his/her state licensing board(s).


Tuition | Course Fee

Live Interactive Webinar presentation

CDE Only | 3-hours continuing dental education
$117 - Dentist or Allied Dental Personnel
New Alumni (2019-2021 Graduate) Complimentary Registration

Course fee is due at time of registration.

Pre-registration is suggested to guarantee receipt of webinar link.


About Our Speaker

 

Ngozi N. Nwizu, BDS, MMSc, PhD is an assistant professor in the Department of Diagnostic and Biomedical Sciences at The University of Texas School of Dentistry at Houston. Dr. Nwizu earned a dental degree from the University of Lagos in Lagos, Nigeria, and a Master of Medical Science degree in oral pathology from the University of Glasgow, Scotland, U.K. She also completed her residency in oral and maxillofacial pathology, earned a specialty certification, and a doctorate degree in pathology from the State University of New York at Buffalo, N.Y.

Dr. Nwizu teaches pathobiology, oral diseases, and oral mucosal diseases at the School of Dentistry, where she also provides oral pathology consults. Dr. Nwizu is a board-certified diplomate of the American Board of Oral and Maxillofacial Pathology and a fellow of both the American Academy of Oral Medicine and the American Academy of Oral and Maxillofacial Pathology. 

 

 


 

Kalu U. E. Ogbureke, BDS, DMSc, JD, MSc, is a tenured Professor of Oral and Maxillofacial/Head and Neck Pathology, and former Chair of the Department of Diagnostic and Biomedical Sciences at The University of Texas Health Science Center at Houston School of Dentistry (UTHealth). Ogbureke holds several visiting professorships at institutions in the United States and abroad. Heearned his dental degree from the University of Ibadan in Nigeria, a master’s degree in medical science from the University of Glasgow in Scotland, a doctor of medical sciences (DMSc, Molecular/Oral Biology) from Harvard University, and a juris doctorate (JD, Law) from Suffolk University Law School in Boston. He earned the fellowship in dental surgery of the Royal College of Surgeons of England (FDSRCS), the Royal College of Physicians and Surgeons of Glasgow (FDSRCPS), and the Royal College of Surgeons of Edinburgh (FDSRCSE). Ogbureke also earned a graduate certificate in the Business of Medicine from Johns Hopkins University. He completed a 2½-year clinical research fellowship at the National Institutes of Health (NIH), Bethesda, Maryland. He is a board-certified diplomate of the American Board of Oral and Maxillofacial Pathology (ABOMP), a fellow of the Royal College of Pathologists (FRCPath) of the United Kingdom, a board-certified diplomate of the American Board of Medical Malpractice (ABMM) and the American Board of Legal Medicine (ABLM), and a fellow of the American College of Legal Medicine (ACLM). Ogbureke underwent training in Forensic Dentistry through the Forensic Dentistry program of McGill University, Montreal, Canada. He has been inducted into the fellowship of the American College of Dentists (FACD). Ogbureke is the principal investigator studying the role of the SIBLLING family of proteins in oral cancer and precancers. His clinical practice is in the specialty of diagnostic Oral and Maxillofacial Histopathology, Head and Neck Pathology, and Clinical Oral Medicine. Ogbureke has received several awards, including the inaugural Neal W. Chilton Fellowship in Clinical Research by the American Association for Dental Research (AADR) and the Emerging Scientist award by from Augusta University (AU) Research Institute. He was named a Fulbright Scholar (2010; University of Lagos, Nigeria) and a Fulbright Distinguished Chair (2018; University of Birmingham, United Kingdom), and received a Certificate of Congressional Recognition by the United States House of Representative. Ogbureke is a 2016 King James IV Professor of the Royal College of Surgeons of Edinburgh. He is an attorney admitted to practice law in three United States Jurisdictions (Georgia, Massachusetts, District of Columbia) and the United States Supreme Court. His interest is in Health Law and Policy, and Forensic Odontology, and is a frequent invited speaker on aspects of the interface between law and medicine at the annual meetings of the American College of Legal Medicine. Ogbureke has authored and co-authored numerous peer reviewed scientific articles in high impact journals and book chapters. He is the editor of the book titled Oral Cancer.

 


 

Nadarajah Vigneswaran, BDS, DMD, DrMedDent, is a professor in the UTHealth School Dentistry in the Department of Diagnostic and Biomedical Sciences. He earned a Dr.Med.Dent in Immunopathology at University of Erlangen, Germany and a DMD at UAB School of Dentistry. He completed his residency in Oral and Maxillofacial Pathology at the Emory University School of Medicine and his Dental Oncology Fellowship at the UAB School of Dentistry. He is an oral and maxillofacial pathologist who is involved in the diagnosis and management of patients with various oral mucosal disorders. He directs the UTSD-Houston Oral and Maxillofacial Pathology Biopsy service, which process approximately 5,000 cases per year, and is one of the largest biopsy services for the dental profession, in this country. He is actively involved in both clinical and laboratory-based research, related to oral cancer and its precursors. His clinical research focuses on evaluating non-invasive diagnostic devices for early diagnosis of oral cancer and its precursor lesions. His basic research involves the development of experimental animal models for pre-clinical testing of molecular targeted diagnostic imaging and therapy. He also has more than 120 peer reviewed scientific publications in high-impact journals and 6 chapters in medical dental textbooks. He has been an invited presenter for national and international research conference and received over $ 7.5 million in grant funding from Federal (NIH), State (CPRIT) and Local (UTHealth CTSA Consortium) as a principal- and co-investigator.

 



Credit Hours

730 Oral Medicine, Oral Diagnosis, Oral Pathology - Lecture: Hours - 3

 


Schedule

Time:

Webinar Link Opens | 8:30 AM (CST)

Presentation | 9:00 AM - 12:00 PM (CST)

Location:

Virtual CDE | Live Interactive Webinar



Share This

Contact Us
UTHealth School of Dentistry
PACE Center, Continuing Dental Education
7500 Cambridge St., Suite 6152
Houston, TX 77054
Ph: 713-486-4028
Fax: 713-486-4037

Email: PACE@uth.tmc.edu